Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Frans Van de Werf,
Mr Hiroki Shiomi
Read the ESC Press release
Presenter | see Discussant report
Presentation webcastPresentation slides
List of Authors: Shiomi Hiroki, Furukawa Yutaka, Morimoto Takeshi, Shizuta Satoshi, Hayano Mamoru, Tazaki Junichi, Imai Masao, Yamaji Kyohei, Hanazawa Koji, Nagao Kazuya, Saijo Sayaka, Funakoshi Shunsuke, Komiya Tatsuhiko, Sakata Ryuzo, Okabayashi Hitoshi, Hanyu Michiya, Nishiwaki Noboru, Shimamoto Mitsuomi, Kimura Takeshi
Backgrounds: Long-term outcome of percutaneous coronary intervention (PCI) compared with coronary artery bypass grafting (CABG) in patients with triple vessel coronary artery disease (TVD) remains to be elucidated. Objective: We sought to compare long-term outcome after PCI and CABG in TVD patients stratified by the SYNTAX score. Methods: We identified 2981 patients with TVD (PCI: N=1825, CABG: N=1156) among 15263 patients with first coronary revascularization enrolled in the CREDO-Kyoto PCI/CABG registry cohort-2. Main outcome measure of the current analysis is a composite of death/myocardial infarction (MI)/stroke . Results: PCI as compared with CABG was associated with higher 3-year risk for the primary endpoint (adjusted hazard ratio (HR) 1.47 [95% confidence interval (CI): 1.13-1.92, P=.004]), and MI (HR 2.39 [95%CI: 1.31-4.36, P=.004]). Although the risk for all-cause death was significantly higher after PCI (HR 1.62 [95%CI: 1.16-2.27, P=.005]), risk for cardiac death was not significantly different (HR 1.30 [95%CI: 0.81-2.07, P=.28]). Cumulative incidence of the primary endpoint was not different between the PCI and CABG groups in patients with low (<23, N=874 and N=257) and intermediate SYNTAX score (23-32, N=638 and N=388), while in patients with high SYNTAX score (≥ 33, N=280 and N=375), it was markedly higher after PCI than after CABG (15.8% and 12.5%, P=.25, 18.8% and 16.7%, P=.24, and 27.0% and 16.4%, P=.004, respectively). However, the adjusted risk of PCI relative to CABG for the primary endpoint was HR 1.66 (95% CI: 1.04-2.65, P=.03) in the low-score category, HR 1.24 (95% CI: 0.83-1.85, P=.29) in the intermediate-score category, and HR 1.59 (95% CI: 0.998-2.54, P=.051) in the high-score category, respectively. Conclusions: PCI as compared with CABG was associated with significantly higher risk for serious adverse events in TVD patients. Further studies are warranted to investigate whether PCI could be a viable option in TVD patients with less complex coronary anatomy. Discussant | see Presenter abstract
Frans Van de Werf(Belgium)
707009 - 707010
Hot Line II - Frontiers in interventional and device treatments